...
首页> 外文期刊>Biomaterials >Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles
【24h】

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

机译:使用分层的双氢氧化物纳米粒子共同递送siRNA和抗癌药物

获取原文
获取原文并翻译 | 示例
           

摘要

In this research we employed layered double hydroxide nanoparticles (LDHs) to simultaneously deliver an anticancer drug 5-fluorouracil (5-FU) and Allstars Cell Death siRNA (CD-siRNA) for effective cancer treatment. The strategy takes advantage of the LDH anion exchange capacity to intercalate 5-FU into its interlayer spacing and load siRNA on the surface of LDH nanoparticles. LDH nanoparticles have been previously demonstrated as an effective cellular delivery system for 5-FU and siRNA separately in various investigations. More excitedly, the combination of CD-siRNA and anticancer drug 5-FU with the same LDH particles significantly enhanced cytotoxicity to three cancer cell lines, e.g. MCF-7, U2OS and HCT-116, compared to the single treatment with either CD-siRNA or 5-FU. This enhancement is probably a result of coordinate mitochondrial damage process. Thus, the strategy to co-deliver siRNA and an anticancer drug by LDHs has great potential to overcome the drug resistance and enhance cancer treatment.
机译:在这项研究中,我们采用了层状双氢氧化物纳米粒子(LDHs)同时递送抗癌药物5-氟尿嘧啶(5-FU)和Allstars细胞死亡siRNA(CD-siRNA),以有效治疗癌症。该策略利用了LDH阴离子交换能力,将5-FU插入其层间间隔并将siRNA负载在LDH纳米颗粒的表面上。先前已在各种研究中分别证明了LDH纳米颗粒可作为5-FU和siRNA的有效细胞递送系统。更令人兴奋的是,CD-siRNA和抗癌药5-FU与相同的LDH颗粒的组合显着增强了对三种癌细胞系(例如,癌细胞)的细胞毒性。与使用CD-siRNA或5-FU进行的单次治疗相比,MCF-7,U2OS和HCT-116有所提高。这种增强可能是协调性线粒体损伤过程的结果。因此,LDHs共同递送siRNA和抗癌药物的策略具有克服耐药性和增强癌症治疗的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号